Yahoo Finance Centogene (NASDAQ:CNTG) investors are sitting on a loss of 66% if they invested a year ago
Even the best stock pickers will make plenty of bad investments. Unfortunately, shareholders of Centogene N.V. (NASDAQ:CNTG) have suffered share price declines over the last year. To wit the share price is down 66% in that time. We wouldn't rush to judgement on Centogene because we don't have a long term history to look at. The falls have accelerated recently, with the share price down 30% in the last three months.
With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.
View our latest analysis for Centogene
Given that Centogene didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
In the last twelve months, Centogene increased its revenue by 48%. That's well above most other pre-profit companies. Meanwhile, the share price slid 66%. This could mean hype has come out of the stock because the bottom line is concerning investors. We'd definitely consider it a positive if the company is trending towards profitability. If you can see that happening, then perhaps consider adding this stock to your watchlist.
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
If you are thinking of buying or selling Centogene stock, you should check out this FREE detailed report on its balance sheet.
A Different Perspective
We doubt Centogene shareholders are happy with the loss of 66% over twelve months. That falls short of the market, which lost 6.7%. That's disappointing, but it's worth keeping in mind that the market-wide selling wouldn't have helped. With the stock down 30% over the last three months, the market doesn't seem to believe that the company has solved all its problems. Basically, most investors should be wary of buying into a poor-performing stock, unless the business itself has clearly improved. It's always interesting to track share price performance over the longer term. But to understand Centogene better, we need to consider many other factors. For instance, we've identified 4 warning signs for Centogene that you should be aware of.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
